» Articles » PMID: 18212811

Drug Insight: Selective Agonists and Antagonists of the Glucocorticoid Receptor

Overview
Specialty Endocrinology
Date 2008 Jan 24
PMID 18212811
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Glucocorticoid hormones exert a wide spectrum of metabolic and immunological effects. They function through the glucocorticoid receptor, a member of the nuclear receptor superfamily. Glucocorticoids are particularly effective as anti-inflammatory agents but often cause severe side effects. The structure of the ligand-binding domain of the glucocorticoid receptor has now been elucidated, and a series of studies have shown that even subtle changes to the ligand structure alter the final conformation of the ligand-receptor complex, with consequences for both protein recruitment and the function of the receptor. This has led to concerted efforts to find selective ligands for the glucocorticoid receptor that preserve the beneficial anti-inflammatory activity but reduce the side-effect profile. The direct health-care benefits of such a simple, safe, orally active agent targeting the underlying inflammatory process in, for example, rheumatoid arthritis would be considerable in terms of reduced patient suffering; furthermore, the indirect benefits in terms of reducing the costs of therapeutic delivery and preventing loss of productivity would be even greater.

Citing Articles

Merging Natural Product Structures with Pharmaceutical Leads: Unnatural Enantiomers of Estranes as Glucocorticoid Receptor Modulators That Suppress TNF-α and IL-6 Release.

Nicholson J, Yang D, Koelblen T, Hu E, Coss C, Burris T J Med Chem. 2024; 67(18):16185-16194.

PMID: 39240657 PMC: 11609614. DOI: 10.1021/acs.jmedchem.4c01007.


modeling of glucocorticoid mechanisms in stress-related mental disorders: Current challenges and future perspectives.

Bassil K, de Nijs L, Rutten B, van den Hove D, Kenis G Front Cell Dev Biol. 2022; 10:1046357.

PMID: 36518537 PMC: 9742534. DOI: 10.3389/fcell.2022.1046357.


Nuclear receptor ligand screening in an iPSC-derived in vitro blood-brain barrier model identifies new contributors to leptin transport.

Shi Y, Kim H, Hamann C, Rhea E, Brunger J, Lippmann E Fluids Barriers CNS. 2022; 19(1):77.

PMID: 36131285 PMC: 9494897. DOI: 10.1186/s12987-022-00375-3.


The maternal-placental-fetal interface: Adaptations of the HPA axis and immune mediators following maternal stress and prenatal alcohol exposure.

Ruffaner-Hanson C, Noor S, Sun M, Solomon E, Marquez L, Rodriguez D Exp Neurol. 2022; 355:114121.

PMID: 35605668 PMC: 10207636. DOI: 10.1016/j.expneurol.2022.114121.


Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study.

Senkova A, Savin I, Brenner E, Zenkova M, Markov A PLoS One. 2021; 16(11):e0260450.

PMID: 34807957 PMC: 8608348. DOI: 10.1371/journal.pone.0260450.